Urinary Cancer Risk Test 'MySignal®︎' Begins Sales at 224 'Kusuri no Lady' Stores
AI Summary (NQ-processed)
Bio-AI startup Craif Inc. has launched its urinary cancer risk test 'MySignal®︎' at 224 'Kusuri no Lady' stores operated by Lady Pharmacy Co., Ltd. This initiative aims to lower the barriers to cancer screening and raise awareness for early detection by making the test easily accessible.
AI Analysis
Frequently Asked Questions
Q: Where can I purchase 'MySignal®︎'?
A: It is available for purchase at the counters of 224 'Kusuri no Lady' stores nationwide and through their online shop, 'Kusuri no Lady Heart Shop'.
Q: What are the benefits of undergoing a cancer risk test?
A: Understanding your cancer risk early can lead to lifestyle improvements and timely medical consultations, increasing the chances of cancer prevention, early detection, and early treatment.
Q: What types of cancer can 'MySignal®︎' test for?
A: 'MySignal Scan' evaluates the risk for 10 types of cancer, including pancreatic cancer. Other products also assess or monitor cancer-related risks.
Q: How accurate are the test results?
A: While high-accuracy risk assessment is performed using AI and microRNA technology, it is not a diagnostic tool as it is not a medical device. Please use it solely for risk assessment.
Q: What are Craif's future plans?
A: Craif plans to continue expanding its offerings through pharmacies and drugstores to provide more people with opportunities for early cancer detection.